These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 22925155)
1. Immunohistochemical expression of the proliferative marker Ki67 in hydatidiform moles and its diagnostic value in the progression to gestational trophoblastic neoplasia. Hasanzadeh M; Sharifi N; Esmaieli H; Daloee MS; Tabari A J Obstet Gynaecol Res; 2013 Feb; 39(2):572-7. PubMed ID: 22925155 [TBL] [Abstract][Full Text] [Related]
2. Assessment of Her-2/neu expression in hydatidiform moles for prediction of subsequent gestational trophoblastic neoplasia. Menczer J; Schreiber L; Berger E; Golan A; Levy T Gynecol Oncol; 2007 Mar; 104(3):675-9. PubMed ID: 17126893 [TBL] [Abstract][Full Text] [Related]
3. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study. Kim BW; Cho H; Kim H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909 [TBL] [Abstract][Full Text] [Related]
4. Can Ki67 and Caspase Predict Molar Progression? Nagib RM; M A Zaki M; Wageh A; Abdelrazik M Fetal Pediatr Pathol; 2019 Oct; 38(5):444-448. PubMed ID: 31038005 [No Abstract] [Full Text] [Related]
5. Decidual infiltration of FoxP3⁺ regulatory T cells, CD3⁺ T cells, CD56⁺ decidual natural killer cells and Ki-67 trophoblast cells in hydatidiform mole compared to normal and ectopic pregnancies. Sundara YT; Jordanova ES; Hernowo BS; Gandamihardja S; Fleuren GJ Mol Med Rep; 2012 Jan; 5(1):275-81. PubMed ID: 22002546 [TBL] [Abstract][Full Text] [Related]
6. Prediction of persistent gestational trophobalstic neoplasia: the role of hCG level and ratio in 2 weeks after evacuation of complete mole. Kang WD; Choi HS; Kim SM Gynecol Oncol; 2012 Feb; 124(2):250-3. PubMed ID: 22094931 [TBL] [Abstract][Full Text] [Related]
7. PTEN and MDM2 expression in the prediction of postmolar gestational trophoblastic neoplasia. Lertkhachonsuk R; Tantbirojn P; Paiwattananupant K J Reprod Med; 2012; 57(7-8):333-40. PubMed ID: 22838251 [TBL] [Abstract][Full Text] [Related]
8. Expression of maspin in gestational trophoblastic disease. Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752 [TBL] [Abstract][Full Text] [Related]
9. Apoptotic index for prediction of postmolar gestational trophoblastic neoplasia. Braga A; Maestá I; Rocha Soares R; Elias KM; Custódio Domingues MA; Barbisan LF; Berkowitz RS Am J Obstet Gynecol; 2016 Sep; 215(3):336.e1-336.e12. PubMed ID: 27094961 [TBL] [Abstract][Full Text] [Related]
10. The diagnostic value of p27 in comparison to p57 in differentiation between different gestational trophoblastic diseases. Abdou A; Kandil M; El-Wahed MA; Shabaan M; El-Sharkawy M Fetal Pediatr Pathol; 2013 Dec; 32(6):395-411. PubMed ID: 23438793 [TBL] [Abstract][Full Text] [Related]
11. Subsequent pregnancy outcomes after complete and partial molar pregnancy, recurrent molar pregnancy, and gestational trophoblastic neoplasia: an update from the New England Trophoblastic Disease Center. Vargas R; Barroilhet LM; Esselen K; Diver E; Bernstein M; Goldstein DP; Berkowitz RS J Reprod Med; 2014; 59(5-6):188-94. PubMed ID: 24937955 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA Expression Profiling in Hydatidiform Mole for the Prediction of Postmolar GTN : MicroRNA Profile in Postmolar GTN. Teerapakpinyo C; Areeruk W; Tantbirojn P; Phupong V; Shuangshoti S; Lertkhachonsuk R Technol Cancer Res Treat; 2022; 21():15330338211067309. PubMed ID: 35023789 [No Abstract] [Full Text] [Related]
13. [Expression and significance of LMP2 and PPM1A in gestational trophoblastic disease]. Zhang SS; Wan XY; Zhou CY; Lü WG; Xie X Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):510-5. PubMed ID: 22041443 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of prostate stem cell antigen is associated with gestational trophoblastic neoplasia. Feng HC; Tsao SW; Ngan HY; Xue WC; Kwan HS; Siu MK; Liao XY; Wong E; Cheung AN Histopathology; 2008 Jan; 52(2):167-74. PubMed ID: 18184265 [TBL] [Abstract][Full Text] [Related]
15. Mcl-1 expression in gestational trophoblastic disease correlates with clinical outcome: a differential expression study. Fong PY; Xue WC; Ngan HY; Chan KY; Khoo US; Tsao SW; Chiu PM; Man LS; Cheung AN Cancer; 2005 Jan; 103(2):268-76. PubMed ID: 15578716 [TBL] [Abstract][Full Text] [Related]
16. Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type. Schmitt C; Doret M; Massardier J; Hajri T; Schott AM; Raudrant D; Golfier F Gynecol Oncol; 2013 Jul; 130(1):86-9. PubMed ID: 23523617 [TBL] [Abstract][Full Text] [Related]
17. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles. Baasanjav B; Usui H; Kihara M; Kaku H; Nakada E; Tate S; Mitsuhashi A; Matsui H; Shozu M Hum Reprod; 2010 May; 25(5):1183-91. PubMed ID: 20208060 [TBL] [Abstract][Full Text] [Related]
18. Proteomic identification of predictive biomarkers for malignant transformation in complete hydatidiform moles. Vanichtantikul A; Hodge KG; Somparn P; Saethang T; Triratanachat S; Pisitkun T; Lertkhachonsuk R Placenta; 2019 Feb; 77():58-64. PubMed ID: 30827356 [TBL] [Abstract][Full Text] [Related]